(ANSA) - PARIS, SEPTEMBER 05 - The cost of the future vaccine developed by the Sanofi and Gsk laboratories against Covid-19 "is not yet fully defined" but it will be "less than ten euros" forgive: said Olivier Bogillot, president of SanofiFrance , on France Inter.
Speaking of the price of around € 2.50 per dose announced by the Anglo-Swedish competitor AstraZeneca, Bogillot explained the difference from the fact that Sanofi uses all its resources "internally" while AstraZeneca "has outsourced production".
"The French and Europeans will have the Sanof vaccine at the same time as American patients," he said.
"We signed during the summer with the Americans, the same week with the Europeans and the British", he summarized: the United States will have about 100 million doses, Europeans 300 million and Great Britain 60 million.
(HANDLE).